drugset / Trial / NCT02929056
Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate and compare healing characteristics, reduction in the size of the wound and to measure complete healing of the wound following the application of a biologic product dressing instead of the alginate dressing along with standard debridement and compression therapy versus the standard of care treatment for VLUs. The biologic product that will be used in this study is called AmnioExCel™.
Timeline
- Start
- 2017-02-15
- Primary completion
- 2018-09-06
- Completion
- 2019-10-29
Outcome
Outcome not reported
Stopped (Business): “grant funding ended”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AmnioExCel | Other / unclassified | — | — |